Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV
Jordan E. Lake(The University of Texas Health Science Center at Houston), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Carrie D. Johnston(Apple (Israel)), Jana Taron(University Medical Center Freiburg), Jorge Leon-Cruz(Harvard University), Shobha Swaminathan(Rutgers, The State University of New Jersey), Kayla Paradis(Cancer Research And Biostatistics), Netanya S. Utay(The University of Texas Southwestern Medical Center), Pamela S. Douglas(Duke University), Evelynne S. Fulda(Cancer Research And Biostatistics), Steven Grinspoon(Massachusetts General Hospital), Michael T. Lu(Cancer Research And Biostatistics), Ken Ho(University of Pittsburgh), Emma M. Kileel(Boston University), Kathleen V. Fitch(Harvard University), Markella V. Zanni(Harvard University), Anne F. Luetkemeyer(University of California, San Francisco), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 18
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
|New England Journal of Medicine|2015|1.5k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k